← Back to Search

Pain Management Methods for Clubfoot

Phase 4
Waitlist Available
Led By Jeffrey Martus, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing in-clinic Achilles Tenotomy
Clubfoot patients less than 6 weeks of age at start of casting
Must not have
Patients with a neuromuscular condition (spina bifida, caudal regression syndrome, arthrogryposis, etc.)
Clubfoot patients greater than 6 weeks of age at the start of casting
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, before cast placement to tenotomy procedure at the end of casting, approximately 10 weeks.
Awards & highlights
Drug Has Already Been Approved
Pivotal Trial

Summary

This trial is testing which pain management method, L.M.X.4 Cream vs. J-tip 1% Xylocaine MPF Injection, is better for infants with clubfoot undergoing an in-office percutaneous TAL. The hypothesis is that J-tip 1% Xylocaine MPF injection will provide equal or greater pain control when compared to L.M.X.4 cream.

Who is the study for?
This trial is for infants under 6 weeks old with idiopathic clubfoot who are getting in-clinic Achilles Tenotomy at Vanderbilt DOT 4 Clinic. It's not for those who've had previous clubfoot treatments, are older than 6 weeks at the start of casting, or have neuromuscular conditions like spina bifida.
What is being tested?
The study compares two pain relief methods during a foot procedure for clubfoot: LMX4 cream (a topical anesthetic) and J-Tip needle-free injection system with lidocaine. The goal is to see which provides better pain control without increasing adverse events.
What are the potential side effects?
Possible side effects may include skin reactions where the cream or injection was applied, such as redness or swelling. There might also be differences in how well each method controls pain during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for an Achilles tendon cutting procedure in a clinic.
Select...
My baby is under 6 weeks old and has clubfoot.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition affecting my muscles or nerves, like spina bifida.
Select...
I am over 6 weeks old and have clubfoot.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, before cast placement to tenotomy procedure at the end of casting, approximately 10 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, before cast placement to tenotomy procedure at the end of casting, approximately 10 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
FLACC (Face, Legs, Activity, Cry, Consolability) Scale
Pulse Oximetry

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: J-Tip with 0.25mL of 1% Xylocaine MPF with placebo creamExperimental Treatment1 Intervention
Group II: L.M.X.4 cream with J-Tip saline injectionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
900 Previous Clinical Trials
939,412 Total Patients Enrolled
Jeffrey Martus, MDPrincipal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
7 Total Patients Enrolled

Media Library

In-Office Procedure Clinical Trial Eligibility Overview. Trial Name: NCT04766684 — Phase 4
Clubfoot Research Study Groups: J-Tip with 0.25mL of 1% Xylocaine MPF with placebo cream, L.M.X.4 cream with J-Tip saline injection
Clubfoot Clinical Trial 2023: In-Office Procedure Highlights & Side Effects. Trial Name: NCT04766684 — Phase 4
In-Office Procedure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04766684 — Phase 4
~2 spots leftby Jan 2025